|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
|
US5877193A
(en)
|
1996-07-19 |
1999-03-02 |
Hoffmann-La Roche Inc. |
Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
|
|
US6416780B1
(en)
|
1997-05-07 |
2002-07-09 |
Galen (Chemicals) Limited |
Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
|
|
CA2349832A1
(en)
|
1999-01-13 |
2000-07-20 |
Warner-Lambert Company |
Benzenesulfonamide derivatives and their use as mek inhibitors
|
|
ES2208364T3
(es)
|
1999-07-16 |
2004-06-16 |
Warner-Lambert Company Llc |
Procedimiento para tratar dolor cronico usando inhibidores de mek.
|
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
|
FR2836917B1
(fr)
|
2002-03-11 |
2006-02-24 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif
|
|
AU2003243921B2
(en)
|
2002-06-27 |
2009-05-07 |
Novo Nordisk A/S |
Aryl carbonyl derivatives as therapeutic agents
|
|
WO2004092123A2
(en)
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
|
EP1646628A1
(en)
|
2003-07-08 |
2006-04-19 |
Novartis AG |
Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
|
|
EP1673357A2
(en)
|
2003-08-08 |
2006-06-28 |
Vertex Pharmaceuticals Incorporated |
Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
|
|
HU227684B1
(en)
|
2003-08-29 |
2011-11-28 |
Sanofi Aventis |
Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
|
|
WO2006066109A2
(en)
|
2004-12-17 |
2006-06-22 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
EP1937658A1
(en)
|
2005-10-06 |
2008-07-02 |
Sanofi-Aventis |
4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
|
|
EP2316829A1
(en)
|
2005-12-21 |
2011-05-04 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
WO2008019967A2
(en)
|
2006-08-15 |
2008-02-21 |
F. Hoffmann-La Roche Ag |
Phenyl, pyridine and quinoline derivatives
|
|
CA2666624C
(en)
|
2006-10-19 |
2015-12-29 |
Signal Pharmaceuticals, Llc |
Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors
|
|
US8124610B2
(en)
*
|
2007-07-13 |
2012-02-28 |
Icagen Inc. |
Sodium channel inhibitors
|
|
WO2009012241A1
(en)
|
2007-07-13 |
2009-01-22 |
Icagen, Inc. |
Sodium channel inhibitors
|
|
WO2009013171A2
(en)
|
2007-07-24 |
2009-01-29 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
US7935779B2
(en)
|
2008-03-07 |
2011-05-03 |
Great Eastern Resins Industrial Co., Ltd. |
Synthesis of polyimides (PI) from poly-carbodiimides and dianhydrides by sequential self-repetitive reaction (SSRR)
|
|
KR20110027657A
(ko)
|
2008-06-25 |
2011-03-16 |
다이이찌 산쿄 가부시키가이샤 |
카르복실산 화합물
|
|
WO2010002956A2
(en)
|
2008-07-01 |
2010-01-07 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
GB0815947D0
(en)
|
2008-09-02 |
2008-10-08 |
Univ Dundee |
Compounds
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
PE20120008A1
(es)
|
2009-01-12 |
2012-01-24 |
Icagen Inc |
Derivados de fenoxi bencenosulfonamida
|
|
CA2804593C
(en)
|
2010-07-09 |
2015-11-24 |
Pfizer Limited |
Biphenyloxybenzensulphonamide derivatives useful as sodium channel inhibitors
|
|
KR101541086B1
(ko)
|
2010-08-20 |
2015-08-03 |
허치슨 메디파르마 리미티드 |
피롤로피리미딘 화합물 및 그 용도
|
|
MX2014001851A
(es)
|
2011-08-17 |
2014-10-24 |
Amgen Inc |
Inhibidores del canal de heteroarilo sodio.
|
|
IN2014CN02959A
(enExample)
|
2011-10-28 |
2015-07-03 |
Merck Sharp & Dohme |
|
|
US9630929B2
(en)
|
2011-10-31 |
2017-04-25 |
Xenon Pharmaceuticals Inc. |
Benzenesulfonamide compounds and their use as therapeutic agents
|
|
JP6014155B2
(ja)
|
2011-10-31 |
2016-10-25 |
ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
ビアリールエーテルスルホンアミドおよび治療剤としてのそれらの使用
|
|
US8889741B2
(en)
|
2012-02-09 |
2014-11-18 |
Daiichi Sankyo Company, Limited |
Cycloalkane derivatives
|
|
WO2013122897A1
(en)
|
2012-02-13 |
2013-08-22 |
Amgen Inc. |
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
|
|
ES2798138T3
(es)
|
2012-10-15 |
2020-12-09 |
Dae Woong Pharma |
Bloqueadores de los canales de sodio, método de preparación de los mismos y uso de los mismos
|
|
CA2889378A1
(en)
|
2012-10-26 |
2014-05-01 |
Merck Sharp & Dohme Corp. |
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
|
|
US9388179B2
(en)
|
2012-10-26 |
2016-07-12 |
Merck Sharp & Dohme Corp. |
N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
TW201443025A
(zh)
|
2013-04-19 |
2014-11-16 |
Pfizer Ltd |
化學化合物
|
|
TW201512171A
(zh)
|
2013-04-19 |
2015-04-01 |
Pfizer Ltd |
化學化合物
|
|
US9776995B2
(en)
|
2013-06-12 |
2017-10-03 |
Amgen Inc. |
Bicyclic sulfonamide compounds as sodium channel inhibitors
|
|
GB201310542D0
(en)
|
2013-06-13 |
2013-07-31 |
Antabio Sas |
Compounds
|
|
JP6407285B2
(ja)
|
2013-09-09 |
2018-10-17 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
ＲＯＲγ調節因子
|
|
AU2014318979B2
(en)
|
2013-09-10 |
2019-03-28 |
Chromocell Corporation |
Sodium channel modulators for the treatment of pain and diabetes
|
|
WO2015077905A1
(en)
|
2013-11-29 |
2015-06-04 |
Merck Sharp & Dohme Corp. |
Bicycloamine-substituted-n-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
JP6337124B2
(ja)
|
2013-12-23 |
2018-06-06 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
インダゾール及びその使用
|
|
CN106795149B
(zh)
|
2015-05-05 |
2019-09-24 |
上海海雁医药科技有限公司 |
双环取代的苯磺酰胺衍生物、其制法与医药上的用途
|
|
EP3390374B1
(en)
|
2015-12-18 |
2020-08-26 |
Merck Sharp & Dohme Corp. |
Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
EP3389654B1
(en)
|
2015-12-18 |
2023-08-16 |
Merck Sharp & Dohme LLC |
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
PL3458443T3
(pl)
|
2016-05-03 |
2021-03-08 |
Bayer Pharma Aktiengesellschaft |
Aromatyczne pochodne sulfonamidowe
|
|
HRP20250505T1
(hr)
|
2016-05-20 |
2025-06-20 |
Xenon Pharmaceuticals Inc. |
Spojevi benzensulfonamida i njihova uporaba za terapijska sredstva
|
|
US10968210B2
(en)
|
2016-11-17 |
2021-04-06 |
Merck Sharp & Dohme Corp. |
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
ES2967410T3
(es)
|
2016-12-09 |
2024-04-30 |
Xenon Pharmaceuticals Inc |
Compuestos de bencenosulfonamida y sus usos en forma de agentes terapéuticos
|
|
US10710994B2
(en)
|
2018-03-19 |
2020-07-14 |
Genentech, Inc. |
Oxadiazole transient receptor potential channel inhibitors
|
|
CN112262142B
(zh)
|
2018-06-13 |
2023-11-14 |
泽农医药公司 |
苯磺酰胺化合物及其作为治疗剂的用途
|
|
MX2021001380A
(es)
|
2018-08-31 |
2021-05-27 |
Xenon Pharmaceuticals Inc |
Compuestos de sulfonamida sustituidos con heteroarilo y su uso como agentes terapeuticos.
|
|
MA53488A
(fr)
|
2018-08-31 |
2021-12-08 |
Xenon Pharmaceuticals Inc |
Composés de sulfonamide substitués par hétéroaryle et leur utilisation en tant qu'inhibiteurs de canaux sodiques
|
|
MA53491A
(fr)
|
2018-08-31 |
2021-09-15 |
Cytokinetics Inc |
Inhibiteurs de sarcomes cardiaques
|